Global Intravenous (IV) Equipment Market Segmentation, By Product (Intravenous (IV) Catheters, Administration Sets, Infusion Pumps, Securement Devices, Stopcocks and Check Valves, Drip Chambers, Needleless Connectors and Other Intravenous (IV) Equipment), End User (Hospitals and Clinics, Home Care, Ambulatory Care Centres, and Others) – Industry Trends and Forecast to 2031.
Intravenous (IV) Equipment Market Analysis
A high demand for surgical procedures is being witnessed, especially in developed regions owing to the ageing population suffering from chronic diseases. Intravenous therapy is defined as the use of infusions to deliver desired liquid medications into the veins of the affected individuals.
Intravenous (IV) Equipment Market Size
Global intravenous (IV) equipment market size was valued at USD 14.86 billion in 2023 and is projected to reach USD 24.96 billion by 2031, with a CAGR of 6.70% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Intravenous (IV) Equipment Key Market Insights
|
|
Segmentation
|
By Product: Intravenous (IV) Catheters, Administration Sets, Infusion Pumps, Securement Devices, Stopcocks and Check Valves, Drip Chambers, Needleless Connectors and Other Intravenous (IV) Equipment
By End User: Hospitals and Clinics, Home Care, Ambulatory Care Centres, and Others
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
B. Braun Melsungen AG (Germany), 3M (US), Terumo Corporation (Japan), Abbott (US), Teleflex Incorporated (US), BD (US), Henry Schein, Inc. (US), Smiths Medical (US), Baxter. (US), Ascor S.A. (Switzerland), Moog Inc. (US), AngioDynamics. (US), ICU Medical, Inc. (US), Fresenius SE & Co. KGaA (Germany), Animas LLC (US), arcomed ag (Switzerland), International WIN, LTD. (US), and The Metrix Company. (US), among others
|
Intravenous (IV) Equipment Market Definition
The intravenous (IV) equipment refers to the equipment is utilized to deliver medicine, transfusing blood, rectification of electrolyte imbalances, and maintain blood pressure, among infusing other fluids to the body of the patients. This method is known to be one of the fastest method of providing liquid and solutions to the body.
Intravenous (IV) Equipment Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
- Geriatric Population
The rise in the geriatric population across the globe acts as one of the major factors driving the growth of intravenous (IV) equipment market as ageing population is more prone to chronic diseases.
- Demand for Ambulatory Infusion Pumps
The increase in demand for ambulatory infusion pumps owing to the growing home care sector accelerate the market growth.
- Surgical Procedures
The surge in the number of surgical procedures due to the high prevalence of chronic diseases along with the rising requirement for administering timely medications to patients further influence the market.
Opportunities
Furthermore, increase in the number of needle stick injuries and infections extend profitable opportunities to the market players in the forecast period of 2024 to 2031. Also, high demand for IV equipment with enhanced quality and performance will assist in the expansion of the market.
Restraints/Challenges
On the other hand, risks with safety of patients and medication errors associated with infusion pumps leading to product recalls are expected to obstruct market growth. Also, incidence of medication errors and stringent regulatory requirements are projected to challenge the intravenous (IV) equipment market in the forecast period of 2024-2031.
This intravenous (IV) equipment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on intravenous (IV) equipment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Intravenous (IV) Equipment Market
Covid-19 had a positive impact on the intravenous (IV) equipment market. The medical services such as biopsies witnessed decline in revenues in the years 2020 and 2021 due to the outbreak of COVID-19. Major medical procedures were declined during the pandemic in order to prevent the risk of spreading coronavirus. However, rise in the number of intravenous therapy is expected in the post-COVID owing to the easing of restrictions.
Intravenous (IV) Equipment Market Scope
The intravenous (IV) equipment market is segmented on the basis of product and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Intravenous (IV) Catheters
- Administration Sets
- Infusion Pumps
- Securement Devices
- Stopcocks and Check Valves
- Drip Chambers
- Needleless Connectors
- Other Intravenous (IV) Equipment
Based on the product, the intravenous (IV) equipment market is segmented into intravenous (IV) catheters, administration sets, infusion pumps, securement devices, stopcocks and check valves, drip chambers, needleless connectors and other intravenous (IV) equipment. Administration sets segment is sub-segmented into solution administration sets and blood administration sets.
End User
- Hospitals and Clinics
- Home Care
- Ambulatory Care Centres
- Others
Based on the end user, the intravenous (IV) equipment market is segmented into hospitals and clinics, home care, ambulatory care centres and others.
Intravenous (IV) Equipment Market Regional Analysis
The intravenous (IV) equipment market is analysed and market size insights and trends are provided by country, product and end user as referenced above.
The countries covered in the intravenous (IV) equipment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the intravenous (IV) equipment market because of the presence of a well-established healthcare sector within the region.
Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2024 to 2031 due to the increasing burden of chronic diseases in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The intravenous (IV) equipment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for intravenous (IV) equipment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the intravenous (IV) equipment market. The data is available for historic period 2010-2020.
Intravenous (IV) Equipment Market Share
The intravenous (IV) equipment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to intravenous (IV) equipment market.
Intravenous (IV) Equipment Market Leaders Operating in the Market Are:
- B. Braun Melsungen AG (Germany
- 3M (US)
- Terumo Corporation (Japan)
- Abbott (US)
- Teleflex Incorporated (US)
- BD (US)
- Henry Schein, Inc. (US)
- Smiths Medical (US)
- Baxter. (US)
- Ascor S.A. (Switzerland)
- Moog Inc. (US)
- AngioDynamics. (US)
- ICU Medical, Inc. (US)
- Fresenius SE & Co. KGaA (Germany)
- Animas LLC (US)
- arcomed ag (Switzerland)
- International WIN, LTD. (US)
- The Metrix Company (US)
Latest Developments in Intravenous (IV) Equipment Market
- B. Braun Melsungen AG announced the investment of USD 1 Billion in new and improved IV therapy manufacturing facilities in the U.S. healthcare system in May’2019.
SKU-